Literature DB >> 7001842

Effects of glipizide on the insulin production by isolated mouse pancreatic islets.

A Andersson, L A Borg.   

Abstract

Glipizide was found to stimulate the insulin release from isolated mouse pancreatic islets incubated at 5.5 mM glucose. The rate of insulin biosynthesis under similar conditions was, however, markedly depressed except at the lowest glipizide concentration tested (5 ng/ml), where the drug stimulated insulin secretion but was without effect on the biosynthetic rate. The inhibition of insulin biosynthesis was also observed in experiments with islets maintained in tissue culture, despite the fact that insulin accumulation in the culture medium was increased throughout the culture period. The present data suggest that glipizide has a transient beta-cytotropic effect, which could suggest that extra-pancreatic factors may be involved in the long-term therapeutic action of the drug.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001842

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN: 0300-9750


  4 in total

1.  Characterization of the action of S 21403 (mitiglinide) on insulin secretion and biosynthesis in normal and diabetic beta-cells.

Authors:  Nurit Kaiser; Rafael Nesher; Andrei Oprescu; Suad Efendic; Erol Cerasi
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

Authors:  B H Wolffenbuttel; L Nijst; J P Sels; P P Menheere; P G Müller; A C Kruseman
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Efflux of radioactive nucleotides from mouse pancreatic islets prelabelled with 2-3H-adenosine.

Authors:  M Welsh
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122

Review 4.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.